FDA Inspection 1061287 — CMP Pharma Inc

CMP Pharma Inc — FEI 1050589

The FDA completed an inspection of CMP Pharma Inc on June 28, 2018 in Farmville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 28, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmville, NC (United States)